메뉴 건너뛰기




Volumn 158, Issue 6, 1997, Pages 2872-2881

A Soluble Chimeric Complement Inhibitory Protein That Possesses Both Decay-Accelerating and Factor I Cofactor Activities

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; DECAY ACCELERATING FACTOR; HYBRID PROTEIN; LEUKOCYTE ANTIGEN; MCP PROTEIN, RAT; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN;

EID: 0031569285     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (65)

References (30)
  • 1
    • 0001306164 scopus 로고
    • Complement
    • W. Paul, ed. Raven Press, New York
    • Frank, M., and L. Fries. 1989. Complement. In Fundamental Immunology. W. Paul, ed. Raven Press, New York, p. 679.
    • (1989) Fundamental Immunology , pp. 679
    • Frank, M.1    Fries, L.2
  • 3
    • 0024459884 scopus 로고
    • The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus
    • Negoro, N., M. Okamura, T. Takeda, S. Koda, K. Amatsu, T. Inoue, J. Curd, and Y. Kanayama. 1989. The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus. Arthritis Rheum. 32: 1233.
    • (1989) Arthritis Rheum. , vol.32 , pp. 1233
    • Negoro, N.1    Okamura, M.2    Takeda, T.3    Koda, S.4    Amatsu, K.5    Inoue, T.6    Curd, J.7    Kanayama, Y.8
  • 4
    • 0022003064 scopus 로고
    • Complement activation after myocardial infarction
    • Earis, J., E. Marcuson, and A. Bernstein. 1985. Complement activation after myocardial infarction. Chest 87:186.
    • (1985) Chest , vol.87 , pp. 186
    • Earis, J.1    Marcuson, E.2    Bernstein, A.3
  • 5
    • 0023200891 scopus 로고
    • Neutrophil activation after burn injury: Contribution of the classic complement pathway and of endotoxin
    • Davis, C., F. Moore, M. Rodrick, D. Fearon, and J. Mannick. 1987. Neutrophil activation after burn injury: contribution of the classic complement pathway and of endotoxin. Surgery 102:477.
    • (1987) Surgery , vol.102 , pp. 477
    • Davis, C.1    Moore, F.2    Rodrick, M.3    Fearon, D.4    Mannick, J.5
  • 7
    • 0028337022 scopus 로고
    • Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury
    • Meade, P., W. Shoemaker, T. Donnelly, E. Abraham, M. Jagels, G. Cryer, T. Hugli, M. Bishop, and C. Wo. 1994. Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J. Trauma 16:651.
    • (1994) J. Trauma , vol.16 , pp. 651
    • Meade, P.1    Shoemaker, W.2    Donnelly, T.3    Abraham, E.4    Jagels, M.5    Cryer, G.6    Hugli, T.7    Bishop, M.8    Wo, C.9
  • 8
    • 0024381235 scopus 로고
    • The regulators of complement activation (RCA) gene cluster
    • Hourcade, D., M. Holers, and J. Atkinson. 1989. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:381.
    • (1989) Adv. Immunol. , vol.45 , pp. 381
    • Hourcade, D.1    Holers, M.2    Atkinson, J.3
  • 9
    • 0025847781 scopus 로고
    • Membrane cofactor protein (MCP or CD46): Newest member of the regulators of complement activation gene cluster
    • Liszewski, M., T. Post, and J. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431.
    • (1991) Annu. Rev. Immunol. , vol.9 , pp. 431
    • Liszewski, M.1    Post, T.2    Atkinson, J.3
  • 10
    • 0024334289 scopus 로고
    • Decay-accelerating factor: Biochemistry, molecular biology, and function
    • Lublin, D., and J. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35.
    • (1989) Annu. Rev. Immunol. , vol.7 , pp. 35
    • Lublin, D.1    Atkinson, J.2
  • 12
    • 0022517078 scopus 로고
    • Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b
    • Seya, T., J. Turner, and J. Atkinson. 1986. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163:837.
    • (1986) J. Exp. Med. , vol.163 , pp. 837
    • Seya, T.1    Turner, J.2    Atkinson, J.3
  • 13
    • 0014949207 scopus 로고
    • Cleavage of structural proteins during the assembly of the head of bacteriophage T4
    • Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
    • (1970) Nature , vol.227 , pp. 680
    • Laemmli, U.1
  • 14
    • 0021713655 scopus 로고
    • Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
    • Medof, M., T. Kinoshita, and V. Nussenzweig. 1985. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med. 160:1558.
    • (1985) J. Exp. Med. , vol.160 , pp. 1558
    • Medof, M.1    Kinoshita, T.2    Nussenzweig, V.3
  • 15
    • 0019363999 scopus 로고
    • Effects of pharmacologic agents on the reversed passive Arthus reaction in the rat
    • Chang, Y., and I. Otterness. 1981. Effects of pharmacologic agents on the reversed passive Arthus reaction in the rat. Eur. J. Pharmacol. 69:155.
    • (1981) Eur. J. Pharmacol. , vol.69 , pp. 155
    • Chang, Y.1    Otterness, I.2
  • 16
    • 0015348648 scopus 로고
    • Complement-mediated tissue damage: Contribution of the classical and alternative complement pathways in the Forssman reaction
    • May, J., and M. Frank. 1972. Complement-mediated tissue damage: contribution of the classical and alternative complement pathways in the Forssman reaction. J. Immunol. 108:1517.
    • (1972) J. Immunol. , vol.108 , pp. 1517
    • May, J.1    Frank, M.2
  • 20
    • 0028080349 scopus 로고
    • Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection
    • Fodor, W., B. Williams, L. Matis, J. Madri, S. Rollins, J. Knight, W. Velander, and S. Squinto. 1994. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. USA 91:11153.
    • (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 11153
    • Fodor, W.1    Williams, B.2    Matis, L.3    Madri, J.4    Rollins, S.5    Knight, J.6    Velander, W.7    Squinto, S.8
  • 21
    • 0028278705 scopus 로고
    • Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary
    • Iwata, K., T. Seya, H. Ariga, and S. Nagasawa. 1994. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. J. Immunol. 152:3436.
    • (1994) J. Immunol. , vol.152 , pp. 3436
    • Iwata, K.1    Seya, T.2    Ariga, H.3    Nagasawa, S.4
  • 22
    • 0024619131 scopus 로고
    • Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae
    • Kaneko, I., K. Kamoshida, and S. Takahashi. 1989. Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. J. Antibiot. 42:236.
    • (1989) J. Antibiot. , vol.42 , pp. 236
    • Kaneko, I.1    Kamoshida, K.2    Takahashi, S.3
  • 23
    • 0025120305 scopus 로고
    • The effect of FUT-175 (nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo
    • Issekutz, A., D. Roland, and R. Patrick. 1990. The effect of FUT-175 (nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo. Int. J. Immunopharm. 12:1.
    • (1990) Int. J. Immunopharm. , vol.12 , pp. 1
    • Issekutz, A.1    Roland, D.2    Patrick, R.3
  • 25
    • 0026529491 scopus 로고
    • Heparin and modified heparin inhibit complement activation in vivo
    • Weiler, J., R. Edens, R. Linhardt, and Kapelanski, D. 1992. Heparin and modified heparin inhibit complement activation in vivo. J. Immunol. 148:3210.
    • (1992) J. Immunol. , vol.148 , pp. 3210
    • Weiler, J.1    Edens, R.2    Linhardt, R.3    Kapelanski, D.4
  • 26
    • 0026710492 scopus 로고
    • Inhibition of the alternative pathway of complement by glomerular chondroitin sulphate proteoglycan
    • Quigg, R. 1992. Inhibition of the alternative pathway of complement by glomerular chondroitin sulphate proteoglycan. Immunology 76:373.
    • (1992) Immunology , vol.76 , pp. 373
    • Quigg, R.1
  • 30
    • 0025354456 scopus 로고
    • Soluble human complement receptor type I: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
    • Weissman, H., T. Bartow, M. Leppo, H. Marsh, G. Carson, M. Concino, M. Boyle, K. Roux, M. Weisfeldt, and D. Fearon. 1990. Soluble human complement receptor type I: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146.
    • (1990) Science , vol.249 , pp. 146
    • Weissman, H.1    Bartow, T.2    Leppo, M.3    Marsh, H.4    Carson, G.5    Concino, M.6    Boyle, M.7    Roux, K.8    Weisfeldt, M.9    Fearon, D.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.